Follow-The-Filings

Security

Aldeyra Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 2 new 1 exit max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $32M
qoq N 2 A 4 R 1 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 3,698,682 $19M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 2,829,875 $5M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 1,403,990 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 995,243 $2M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 287,364 $1M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 863,187 $1M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% New 0.0% 266,340 $450 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% New 0.0% 129,693 $219 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 94,094 $487 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$37.54M -$55.85M -$33.85M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $147.81M $104.07M $71.78M
Total non-current assets * $516,578 $534,216 $275,861
Total assets $148.33M $104.61M $72.06M
Total current liabilities $22.26M $18.6M $27.81M
Total non-current liabilities * $6.27M $15M $0.00
Total equity $119.8M $71M $44.25M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$30.33M -$43.21M -$33.35M
Cash from investing $30M -$44.92M $47.74M
Cash from financing -$1.27M -$171,422 $1.12M
Net change in cash -$1.6M -$88.3M $15.51M

ownership over time

filing count by report period · click a bar for that quarter’s holders